Literature DB >> 24227860

Elimination of friend retrovirus in the absence of CD8+ T cells.

Sachiyo Tsuji-Kawahara1, Masaaki Miyazawa.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 24227860      PMCID: PMC3911589          DOI: 10.1128/JVI.03271-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  24 in total

1.  Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.

Authors:  Ronald J Messer; Ulf Dittmer; Karin E Peterson; Kim J Hasenkrug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

2.  Influence of MHC genes on spontaneous recovery from Friend retrovirus-induced leukemia.

Authors:  M Miyazawa; J Nishio; K Wehrly; B Chesebro
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

Review 3.  Host genetic control of spontaneous and induced immunity to Friend murine retrovirus infection.

Authors:  B Chesebro; M Miyazawa; W J Britt
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

4.  Role of natural killer cells in resistance against friend retrovirus-induced leukemia.

Authors:  N Iwanami; A Niwa; Y Yasutomi; N Tabata; M Miyazawa
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia.

Authors:  K E Peterson; M Iwashiro; K J Hasenkrug; B Chesebro
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Toll-like receptor 7 inhibits early acute retroviral infection through rapid lymphocyte responses.

Authors:  Edward P Browne
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

7.  Novel role of CD8(+) T cells and major histocompatibility complex class I genes in the generation of protective CD4(+) Th1 responses during retrovirus infection in mice.

Authors:  Karin E Peterson; Ingunn Stromnes; Ron Messer; Kim Hasenkrug; Bruce Chesebro
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Role and specificity of T-cell subsets in spontaneous recovery from Friend virus-induced leukemia in mice.

Authors:  M N Robertson; G J Spangrude; K Hasenkrug; L Perry; J Nishio; K Wehrly; B Chesebro
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 9.  Molecular biology of Friend viral erythroleukemia.

Authors:  D Kabat
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

10.  Production of monoclonal antibodies reactive with a denatured form of the Friend murine leukemia virus gp70 envelope protein: use in a focal infectivity assay, immunohistochemical studies, electron microscopy and western blotting.

Authors:  M N Robertson; M Miyazawa; S Mori; B Caughey; L H Evans; S F Hayes; B Chesebro
Journal:  J Virol Methods       Date:  1991-10       Impact factor: 2.014

View more
  4 in total

1.  CD8+ T cells are essential for controlling acute friend retrovirus infection in C57BL/6 mice.

Authors:  Jara J Joedicke; Gennadiy Zelinskyy; Ulf Dittmer; Kim J Hasenkrug
Journal:  J Virol       Date:  2014-05       Impact factor: 5.103

2.  Reply to "CD8+ T cells are essential for controlling acute friend virus infection in C57BL/6 mice".

Authors:  Sachiyo Tsuji-Kawahara; Shiki Takamura; Masaaki Miyazawa
Journal:  J Virol       Date:  2014-05       Impact factor: 5.103

3.  Antibody-mediated immune control of a retrovirus does not require the microbiota.

Authors:  Jessica Wilks; Helen Beilinson; Betty Theriault; Alexander Chervonsky; Tatyana Golovkina
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

4.  Class switch recombination and somatic hypermutation of virus-neutralizing antibodies are not essential for control of friend retrovirus infection.

Authors:  Maiko Kato; Sachiyo Tsuji-Kawahara; Yuri Kawasaki; Saori Kinoshita; Tomomi Chikaishi; Shiki Takamura; Makoto Fujisawa; Akira Kawada; Masaaki Miyazawa
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.